InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Freitag Gregory Gene, Director. Director active across 2 companies, notably Axogen, Inc.. Cumulatively, 9 reports have been logged. Total volume traded: €82k. The latest transaction was filed on 1 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations9 total
03,036 shares0
Common Stock
SEC:0000805928-22-000062:0·
€148,8439,250 shares@ €16.09110.0096% mcap51.2% of flow
Common Stock
SEC:0000805928-21-000121·
€148,8439,250 shares@ €16.09110.0096% mcap25.6% of flow
Common Stock
SEC:0000805928-21-000121:0·
€41,2285,882 shares@ €7.0091100.0% of flow
Common Stock
SEC:0001140361-21-021489·
Ideal exit: 12 Mar 2022 (T+270)
€41,2285,882 shares@ €7.00910.098% mcap50.0% of flow
Common Stock
SEC:0001140361-21-021489:0·
Ideal exit: 12 Mar 2022 (T+270)
€72,59524,000 shares@ €3.02480.0047% mcap25.0% of flow
Common Stock
SEC:0000805928-21-000118·
€72,59524,000 shares@ €3.02480.0047% mcap12.5% of flow
Common Stock
SEC:0000805928-21-000118:0·
€69,09222,954 shares@ €3.010.0045% mcap23.8% of flow
Common Stock
SEC:0000805928-21-000099·
€69,09222,954 shares@ €3.010.0045% mcap11.9% of flow
Common Stock
SEC:0000805928-21-000099:0·
9 of 9 declarations
About Freitag Gregory Gene
Gregory Gene Freitag is a Board Member at Axogen, Inc. and PDS Biotechnology Corp. He plays a key role in the governance of the companies, contributing to strategic decision-making. His experience is valuable in guiding growth and innovation initiatives.
